They demonstrated that Human Enhancer of Filamentation Protein 1 (HEF1) promotes EMT and bone invasion in prostate cancer by directly targeting miR-145, which partially inhibits EMT and invasion by downregulating HEF1 (Guo et al., 2013). Here, NEDD9 is linked to prostate cancer.